Daniel Schuppmann

Practice Areas

Artificial Intelligence | IP/IT | Life Sciences | Technology Transactions | Licensing & Technology Transfer | Commercial Agreements | Data Protection

Career

Daniel is a Senior Associate at NEUWERK and advises national and international clients on artificial intelligence, intellectual property, licensing, data protection, commercial agreements and technology transactions. His practice spans several technology-driven industries, with a particular focus on life sciences, healthcare and digital health.

Daniel has extensive experience in drafting and negotiating complex research and development collaborations, licensing and option deals, and IP assignments. He also frequently advises on commercial agreements, including manufacturing and supply arrangements, distribution agreements, clinical trial agreements, service agreements and material transfer agreements.

His clients range from large multinational corporations, investors and fast-growing start-ups to spin-outs, academic institutions and non-profit research organizations.

Publications

Die neuen Standardvertragsklauseln für die Durchführung klinischer Prüfungen, PharmR 2026, 289 (together with Dr. Malin Fischer)

Datenschutz in klinischen Prüfungen aus juristischer Sicht, Presentation German Quality Management Association, March 2024

How to Transfer Intellectual Property from Academia to the Market, Presentation at Life Science Start-up Day 2024

Regulierung von KI durch EU-Gesetzgebung. Was erwartet die Life-Sciences-Industrie durch die geplante KI-Verordnung? Plattform Life Sciences, 3/2022

Rechtliche Fragen der Kommerzialisierung von KI-Systemen, Plattform Life Sciences, 2/2021